[1] |
Sheth VM, Pandya AG. Melasma: a comprehensive update. part I[J]. J Am Acad Dermatol, 2011, 65(4): 689⁃697. DOI: 10.1016/j.jaad.2010.12.046.
|
[2] |
廖康煌.色素障碍性皮肤病//杨国亮.杨国亮皮肤病学[M].上海科学技术文献出版社, 2007: 638⁃639.
|
|
Liao KH. Dermatosis of depigmentation disorder//Yang GL. Yang GL Dermatology[M]. Shanghai science and technology literature press, 2007: 638⁃639.
|
[3] |
Liu H, Lin Y, Nie X, et al. Histological classification of melasma with reflectance confocal microscopy: a pilot study in Chinese patients[J]. Skin Res Technol, 2011, 17(4): 398⁃403. DOI: 10.1111/j.1600⁃0846.2011.00517.x.
|
[4] |
顾华, 罗雯, 刘付华, 等. 无创性皮肤测试在黄褐斑临床分型中的应用及意义[J].皮肤病与性病, 2012, 34(2): 69⁃70, 76. DOI: 10.3969/j.issn.1002⁃1310.2012.02.003.
|
|
Hua GU, Wen L, FU⁃hua L, et al. The application of non⁃invasive physiometry in different clinical type of melasma and its clinical significance[J]. J Dermatol Venereol, 2012, 34(2): 69⁃70, 76. DOI: 10.3969/j.issn.1002⁃1310.2012.02.003.
|
[5] |
谭城, 朱文元, 鲁严. 白癜风皮损黑素细胞HMB⁃45、酪氨酸酶及其相关蛋白1的免疫组化研究[J]. 临床皮肤科杂志, 2003, 32(7): 376⁃378. DOI: 10.3969/j.issn.1000⁃4963.2003.07.003.
|
|
Immunohistochemical study on HMB⁃45, tyrosinase and TRP1 in the residual melanocytes of vitiligo[J]. J Clin Dermatol, 2003, 32(7): 376⁃378. DOI: 10.3969/j.issn.1000⁃4963.2003.07.003.
|
[6] |
Ma Y, Ma L, Guo Q, et al. Expression of bone morphogenetic protein⁃2 and its receptors in epithelial ovarian cancer and their influence on the prognosis of ovarian cancer patients[J]. J Exp Clin Cancer Res, 2010, 29: 85. DOI: 10.1186/1756⁃9966⁃29⁃85.
|
[7] |
Kang WH, Yoon KH, Lee ES, et al. Melasma: histopathological characteristics in 56 Korean patients[J]. Br J Dermatol, 2002, 146(2): 228⁃237.
|
[8] |
Grimes PE, Yamada N, Bhawan J. Light microscopic, immunohis⁃tochemical, and ultrastructural alterations in patients with melasma[J]. Am J Dermatopathol, 2005, 27(2): 96⁃101.
|
[9] |
Lee DJ, Park KC, Ortonne JP, et al. Pendulous melanocytes: a characteristic feature of melasma and how it may occur[J]. Br J Dermatol, 2012, 166(3): 684⁃686. DOI: 10.1111/j.1365⁃2133.2011.10648.x.
|
[10] |
朱丽萍, 刘海洋, 庞勤, 等. 联合治疗黄褐斑的研究进展[J]. 中华皮肤科杂志, 2016, 49(2): 147⁃150. DOI: 10.3760/cma.j.issn.0412⁃4030.2016.02.022.
|
|
Zhu LP, Liu HY, Pang Q, et al. Combination therapy for melasma [J]. Chin J Dermatol, 2016, 49(2): 147⁃150. DOI: 10.3760/cma.j.issn.0412⁃4030.2016.02.022.
|
[11] |
Kang HY, Hwang JS, Lee JY, et al. The dermal stem cell factor and c⁃kit are overexpressed in melasma[J]. Br J Dermatol, 2006, 154(6): 1094⁃1099. DOI: 10.1111/j.1365⁃2133.2006.07179.x.
|
[12] |
王银娟, 顾华, 郭美华, 等. 黄褐斑患者皮损及血液中Toll样受体2和4的表达[J].中华皮肤科杂志, 2015, 48(2): 100⁃103. DOI: 10.3760/cma.j.issn.0412⁃4030.2015.02.010.
|
|
Yinjuan W, Hua G, Meihua G, et al. Expressions of Toll⁃like receptors 2 and 4 in skin lesions and peripheral blood from patients with chloasma[J]. Chin J Dermatol, 2015, 48(2): 100⁃103. DOI: 10.3760/cma.j.issn.0412⁃4030.2015.02.010.
|
[13] |
Kim EH, Kim YC, Lee ES, et al. The vascular characteristics of melasma[J]. J Dermatol Sci, 2007, 46(2): 111⁃116. DOI: 10.1016/j.jdermsci.2007.01.009.
|
[14] |
Ho SG, Chan HH. The Asian dermatologic patient: review of common pigmentary disorders and cutaneous diseases[J]. Am J Clin Dermatol, 2009, 10(3): 153⁃168.
|